Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health
SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ — Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines for honeybees and shrimp. The investment marks a significant step in Yuyu Pharma’s plan to become a more active global player in the fast-growing animal health sector.
Dalan is recognized for delivering the world’s first USDA-approved honeybee vaccine and is now advancing a first-in-class shrimp vaccine aimed at transforming disease management in global aquaculture. This investment will allow Dalan to continue to expand its platform across new species,…
